Global longitudinal strain in the SAFE-HEaRT study (Cardiac SAFEty of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function)
26 August 2018 (08:30 - 12:30)
Organised by:
Abstract
About the speaker
Inova Health System, Fairfax (United States of America)
11 More presentations in this session
Access the full session
The Event
ESC Congress 2018
26 August 2018
08:30 CET
